Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cv Sciences Inc (CVSI)

Cv Sciences Inc (CVSI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 108,343
  • Shares Outstanding, K 99,397
  • Annual Sales, $ 48,240 K
  • Annual Income, $ 10,000 K
  • 60-Month Beta -0.79
  • Price/Sales 1.85
  • Price/Cash Flow 10.35
  • Price/Book 3.41
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.08
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/10/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.02
  • Number of Estimates 3
  • High Estimate -0.02
  • Low Estimate -0.02
  • Prior Year 0.03
  • Growth Rate Est. (year over year) -166.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8301 +51.79%
on 12/30/19
1.2800 -1.56%
on 01/17/20
+0.1950 (+18.31%)
since 12/17/19
3-Month
0.8200 +53.66%
on 12/09/19
2.3900 -47.28%
on 10/28/19
-0.8400 (-40.00%)
since 10/17/19
52-Week
0.8200 +53.66%
on 12/09/19
6.5900 -80.88%
on 03/26/19
-2.9150 (-69.82%)
since 01/17/19

Most Recent Stories

More News
CV Sciences, Inc. to Participate at the 22nd Annual ICR Conference

CV Sciences, Inc.(OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced that Joseph Dowling, the Company's...

CVSI : 1.2600 (+15.60%)
Buoyed Cannabis Sales Push Agencies to Bolster Oversight of its Use

Early in December, Michigan started legally selling recreational cannabis, becoming the first state in the Midwest to legalize adult-use marijuana use. It is now the 10th state to legalize the sale of...

BLOZF : 0.6234 (+0.55%)
BLO.CN : 0.830 (+3.75%)
CVSI : 1.2600 (+15.60%)
KSHB : 1.9600 (+9.50%)
HEXO : 1.62 (-8.99%)
OGI : 3.26 (-4.12%)
Tim Hitchman, PhD, Joins CV Sciences, Inc. as Director of Operations

Hitchman Brings Deep Experience in Product Development, Commercialization and Operations

CVSI : 1.2600 (+15.60%)
CV SCIENCES INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CV Sciences, Inc. - CVSI

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into CV Sciences, Inc. (OTC:...

CVSI : 1.2600 (+15.60%)
MMJ International Holdings Is Disrupting The CBD Market With FDA Huntington's Clinical Trial

ST PETERSBURG, FL / ACCESSWIRE / December 12, 2019 / MMJ International Holdings is changing the CBD market by following FDA drug development guidelines. Recently, class-action lawsuits have been filed...

CVSI : 1.2600 (+15.60%)
CV Sciences to Present at the 12th Annual LD Micro Main Event

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced that Joseph Dowling, the Company's...

CVSI : 1.2600 (+15.60%)
The Smartest Ways to Invest in CBD Growth Right Now

CBD is quickly becoming a multi-billion-dollar business. In fact, sales of products containing CBD are expected to grow 700% in 2019 year over year, says the Brightfield Group. "The CBD market has been...

CBDN.CN : 0.220 (-18.52%)
CURA.CN : 9.550 (+0.42%)
CURLF : 7.3175 (+0.76%)
CVSI : 1.2600 (+15.60%)
HEXO : 1.62 (-8.99%)
HEXO.TO : 2.10 (-9.09%)
FIRE.TO : 0.60 (+9.09%)
SPRWF : 0.4580 (+8.27%)
CV Sciences, Inc. Announces New Distribution Partnership With Southeastern Grocers

New Partnership with Southeastern Grocers Launches PlusCBD(TM) Oil Topical Products and Dietary Supplements at 115 Winn-Dixie Stores in Florida and 37 BI-LO Stores in South Carolina

CVSI : 1.2600 (+15.60%)
Support for Cannabis Continues to Rise Among Consumers and Retailers

Cannabis growth is expected to be incredibly explosive. All thanks to incredible demand from consumers. In the U.S. alone, 61% of Americans support the legalization of cannabis, according to the General...

OGRMF : 8.3500 (+4.64%)
VFRM : 0.9800 (+1.03%)
APHA : 5.27 (+1.54%)
APHA.TO : 6.88 (+1.62%)
GTII.CN : 13.510 (+2.35%)
GTBIF : 10.3300 (+1.74%)
OGI.VN : 6.850 (-0.44%)
OGI : 3.26 (-4.12%)
CVSI : 1.2600 (+15.60%)
CV Sciences, Inc. (CVSI) Reports Q3 Loss, Misses Revenue Estimates

CV Sciences, Inc. (CVSI) delivered earnings and revenue surprises of -300.00% and -32.29%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?...

CVSI : 1.2600 (+15.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade CVSI with:

Key Turning Points

2nd Resistance Point 1.4267
1st Resistance Point 1.3433
Last Price 1.2600
1st Support Level 1.1133
2nd Support Level 0.9667

See More

52-Week High 6.5900
Fibonacci 61.8% 4.3859
Fibonacci 50% 3.7050
Fibonacci 38.2% 3.0241
Last Price 1.2600
52-Week Low 0.8200

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar